Please enable JavaScript
Powered by Benchmark International Archives - Page 1249 of 1827 - Matribhumi Samachar English
Monday, January 12 2026 | 07:27:26 PM
Home / International (page 1249)

International

Turnium Technology Group Provides Updates on Non-Brokered Offerings

Vancouver, Canada–(Newsfile Corp. – May 8, 2025) – Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) (“Turnium” or “the Company”), a global leader in Technology-as-a-Service (TaaS) and partner enablement services, including an AI-powered prospecting and lead generation platform, is pleased to announce a non-brokered private placement, of up to 28,561,428 …

Read More »

Hemostemix at Invest Stuttgart

Calgary, Alberta–(Newsfile Corp. – May 8, 2025) –  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is poised to make a significant impact at Invest Stuttgart 2025, Germany’s premier finance and investment conference, taking place from May 9-10, 2025 at Messe Stuttgart. The event attracts thousands …

Read More »

Argo’s Year-End 2024 Oil Reserves Report

Toronto, Ontario–(Newsfile Corp. – May 8, 2025) – Argo Gold Inc’s. (CSE: ARQ) (OTC Pink: ARBTF) (XFRA: A2ASDS) (XSTU: A2ASDS) (XBER: A2ASDS) (“Argo” or the “Company”) Year-End 2024 Reserves Report (“Reserves Report”), with an effective date of December 31, 2024, is summarized below. The Reserves Report was completed by Petrotech …

Read More »

BTCS Highlights Ethereum’s Successful Pectra Upgrade

Silver Spring, Maryland–(Newsfile Corp. – May 8, 2025) –  BTCS Inc. (NASDAQ: BTCS) (“BTCS” or the “Company”), a U.S.-based blockchain infrastructure technology company, today highlighted the successful implementation of the Ethereum network upgrade, Pectra, which went live yesterday May 7, 2025. As part of its ongoing commitment to Ethereum infrastructure, …

Read More »

BioMark Diagnostics Announces Uplisting to OTCQB Venture Market

Milestone strengthens transparency and credibility as the Company advances commercialization of its metabolomics technology platform Vancouver, British Columbia–(Newsfile Corp. – May 8, 2025) – BioMark Diagnostics Inc. (CSE: BUX) (OTCQB: BMKDF) (FSE: 20B) (“BioMark” or the “Company”), a leading developer of liquid biopsy tests for early cancer detection, is pleased …

Read More »